×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GMED – globus medical, inc. class a (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GMED
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/18
10:19 am
gmed
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Truist Financial Co. from $85.00 to $90.00. They now have a "hold" rating on the stock.
Medium
Report
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Truist Financial Co. from $85.00 to $90.00. They now have a "hold" rating on the stock.
12/18
07:09 am
gmed
Confocal Microscope Market is Projected to Reach $1.8 Billion with 3.3% CAGR by 2034 | Fact.MR Report [Yahoo! Finance]
Low
Report
Confocal Microscope Market is Projected to Reach $1.8 Billion with 3.3% CAGR by 2034 | Fact.MR Report [Yahoo! Finance]
12/17
01:32 pm
gmed
Reasons to Retain STE Stock in Your Portfolio Now [Yahoo! Finance]
Low
Report
Reasons to Retain STE Stock in Your Portfolio Now [Yahoo! Finance]
12/17
11:21 am
gmed
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Roth Mkm from $100.00 to $115.00. They now have a "buy" rating on the stock.
Low
Report
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Roth Mkm from $100.00 to $115.00. They now have a "buy" rating on the stock.
12/12
01:07 pm
gmed
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at BTIG Research from $87.00 to $91.00. They now have a "buy" rating on the stock.
Low
Report
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at BTIG Research from $87.00 to $91.00. They now have a "buy" rating on the stock.
12/11
10:48 am
gmed
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Wells Fargo & Company from $88.00 to $95.00. They now have an "overweight" rating on the stock.
Low
Report
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Wells Fargo & Company from $88.00 to $95.00. They now have an "overweight" rating on the stock.
12/11
09:27 am
gmed
Paragon 28 Appoints Dave Demski to Board of Directors [Yahoo! Finance]
Low
Report
Paragon 28 Appoints Dave Demski to Board of Directors [Yahoo! Finance]
12/11
09:27 am
gmed
5 Medical Device Stocks That Survived the 2024 Market Volatility [Yahoo! Finance]
Low
Report
5 Medical Device Stocks That Survived the 2024 Market Volatility [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/5/2024
04:15 pm
GMED
globus medical, inc. class a
BEAT
Report
9.4%
globus medical, inc. class a
8/6/2024
04:15 pm
GMED
globus medical, inc. class a
BEAT
Report
2.1%
globus medical, inc. class a
5/7/2024
04:15 pm
GMED
globus medical, inc. class a
BEAT
Report
20.2%
globus medical, inc. class a
2/20/2024
04:15 pm
GMED
globus medical, inc. class a
BEAT
Report
1.6%
globus medical, inc. class a
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/4
04:13 pm
gmed
Form 4 GLOBUS MEDICAL INC For: Dec 02 Filed by: Huller Kelly
Low
Report
Form 4 GLOBUS MEDICAL INC For: Dec 02 Filed by: Huller Kelly
12/2
04:36 pm
gmed
Form 144 GLOBUS MEDICAL INC Filed by: Huller Kelly
Low
Report
Form 144 GLOBUS MEDICAL INC Filed by: Huller Kelly
11/25
04:35 pm
gmed
Form 4 GLOBUS MEDICAL INC For: Nov 21 Filed by: Davidar David D
Low
Report
Form 4 GLOBUS MEDICAL INC For: Nov 21 Filed by: Davidar David D
11/25
04:31 pm
gmed
Form 4 GLOBUS MEDICAL INC For: Nov 21 Filed by: Lemaitre Dan
Low
Report
Form 4 GLOBUS MEDICAL INC For: Nov 21 Filed by: Lemaitre Dan
11/25
04:29 pm
gmed
Form 4 GLOBUS MEDICAL INC For: Nov 21 Filed by: Scavilla Daniel T
Low
Report
Form 4 GLOBUS MEDICAL INC For: Nov 21 Filed by: Scavilla Daniel T
11/21
07:12 pm
gmed
Form 144 GLOBUS MEDICAL INC Filed by: Davidar David D
Low
Report
Form 144 GLOBUS MEDICAL INC Filed by: Davidar David D
11/21
07:05 pm
gmed
Form 144 GLOBUS MEDICAL INC Filed by: Davidar David D
Low
Report
Form 144 GLOBUS MEDICAL INC Filed by: Davidar David D
11/21
06:55 pm
gmed
Form 144 GLOBUS MEDICAL INC Filed by: Davidar David D
Low
Report
Form 144 GLOBUS MEDICAL INC Filed by: Davidar David D
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/1
Globus Medical Reports Second Quarter 2019 Results
8.5%
4/16 Globus Medical Schedules First Quarter 2020 Earnings Release and Conference Call 6.4%
11/6 Q3/2019 9/30/2019 EPS 0.430 ZacksConsensus 0.430 ActVsEst 0.000 - In-Line 3.2%
3/27 Globus Medical Inc (NYSE: GMED) had its price target lowered by analysts at Morgan Stanley from $60.00 to $48.00. They now have an "equal weight" rating on the stock. 2.8%
11/8 Globus Medical Inc (NYSE: GMED) had its price target raised by analysts at Piper Jaffray Companies from $62.00 to $65.00. They now have an "overweight" rating on the stock. 1.8%
12/11 Globus Medical: 3 Keys To Investing In Late-Cycle Markets [Seeking Alpha] 1.6%
5/3 Form 3 GLOBUS MEDICAL INC For: May 01 Filed by: ZARRILLI STEPHEN T 1.5%
2/4 Medical Devices Are Key to Solving the Healthcare Industry's Persistent Problems 1.2%
12/17 Form 3 GLOBUS MEDICAL INC For: Dec 11 Filed by: Douglas Robert Andrew 1.1%
3/11 Globus Medical Announces $200 Million Share Repurchase Program 1.1%
4/16 Globus Medical Schedules First Quarter 2020 Earnings Release and Conference Call 6.4%
11/6 Q3/2019 9/30/2019 EPS 0.430 ZacksConsensus 0.430 ActVsEst 0.000 - In-Line 3.2%
3/27 Globus Medical Inc (NYSE: GMED) had its price target lowered by analysts at Morgan Stanley from $60.00 to $48.00. They now have an "equal weight" rating on the stock. 2.8%
11/8 Globus Medical Inc (NYSE: GMED) had its price target raised by analysts at Piper Jaffray Companies from $62.00 to $65.00. They now have an "overweight" rating on the stock. 1.8%
12/11 Globus Medical: 3 Keys To Investing In Late-Cycle Markets [Seeking Alpha] 1.6%
5/3 Form 3 GLOBUS MEDICAL INC For: May 01 Filed by: ZARRILLI STEPHEN T 1.5%
2/4 Medical Devices Are Key to Solving the Healthcare Industry's Persistent Problems 1.2%
12/17 Form 3 GLOBUS MEDICAL INC For: Dec 11 Filed by: Douglas Robert Andrew 1.1%
3/11 Globus Medical Announces $200 Million Share Repurchase Program 1.1%
TOP News Decliners
1/8
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
-6.8%
3/18 Globus Medical Inc (NYSE: GMED) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. -4.0%
1/10 Globus Medical Inc (NYSE: GMED) had its "buy" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $64.00 price target on the stock. -2.8%
2/24 Globus Medical Inc (NYSE: GMED) had its "buy" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $67.00 price target on the stock. -2.1%
2/20 Q4/2019 12/31/2019 EPS 0.490 ZacksConsensus 0.510 ActVsEst (0.020) - Miss -1.9%
1/2 Is Globus Medical, Inc.'s (NYSE:GMED) 11% ROE Strong Compared To Its Industry? [Yahoo! Finance News] -1.9%
8/3 Globus Medical, Inc. (GMED) CEO Dave Demski on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -1.8%
9/24 Globus Medical Launches AUTOBAHN® Intramedullary Nailing Platform at 2019 OTA Annual Meeting -1.7%
2/6 Globus Medical Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call -1.6%
10/8 Globus Medical Inc (NYSE: GMED) had its price target raised by analysts at Wells Fargo & Co from $42.00 to $53.00. They now have a "market perform" rating on the stock. -1.4%
3/18 Globus Medical Inc (NYSE: GMED) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. -4.0%
1/10 Globus Medical Inc (NYSE: GMED) had its "buy" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $64.00 price target on the stock. -2.8%
2/24 Globus Medical Inc (NYSE: GMED) had its "buy" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $67.00 price target on the stock. -2.1%
2/20 Q4/2019 12/31/2019 EPS 0.490 ZacksConsensus 0.510 ActVsEst (0.020) - Miss -1.9%
1/2 Is Globus Medical, Inc.'s (NYSE:GMED) 11% ROE Strong Compared To Its Industry? [Yahoo! Finance News] -1.9%
8/3 Globus Medical, Inc. (GMED) CEO Dave Demski on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -1.8%
9/24 Globus Medical Launches AUTOBAHN® Intramedullary Nailing Platform at 2019 OTA Annual Meeting -1.7%
2/6 Globus Medical Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call -1.6%
10/8 Globus Medical Inc (NYSE: GMED) had its price target raised by analysts at Wells Fargo & Co from $42.00 to $53.00. They now have a "market perform" rating on the stock. -1.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: